Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

By M. Scanlan, A. Gure, A. Jungbluth, Lloyd J. Old, Yao-Tseng Chen. Immunological Reviews, 2002

893 citations recorded by the source corpus.

Subfields: Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/13cadee9e67644d3729d471bc3757c70e9fe173f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Lloyd J. Old
2. Robert Schreiber

Citations in the corpus

• The cancer/testis genes: review, standardization, and commentary. (2004, background): “The cDNA templates consisted of commercially available, normalized cDNA panels (MTC panels I and II, BD Biosciences, Palo Alto CA) encompassing 16 normal tissues (including the three gametogenic tissues ovary, testis and placenta), obtained from multiple (3-500) disease-free individuals.”
• Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans (2013, neutral): “We assessed specific T-cell responses to NY-ESO-1, a cancer/testis antigen, which is normally expressed by human germ-line cells and also by various types of cancer cells (4, 22).”